References
- Siegel DA, King J, Tai E, Buchanan N, Ajani UA, Li J: Cancer incidence rates and trends among children and adolescents in the United States, 2001-2009. Pediatrics 2014, 134(4):e945-955.
- Heare T, Hensley MA, Dell’Orfano S: Bone tumors: osteosarcoma and Ewing’s sarcoma. Current opinion in pediatrics 2009, 21(3):365-372.
- Mirabello L, Troisi RJ, Savage SA: Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer 2009, 115(7):1531-1543.
- Luetke A, Meyers PA, Lewis I, Juergens H: Osteosarcoma treatment - where do we stand? A state of the art review. Cancer treatment reviews 2014, 40(4):523-532.
- Esiashvili N, Goodman M, Marcus RB, Jr.: Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data. Journal of pediatric hematology/oncology 2008, 30(6):425-430.
- Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA et al: Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. The New England journal of medicine 2003, 348(8):694-701.
- Benedetti MG, Bonatti E, Malfitano C, Donati D: Comparison of allograft-prosthetic composite reconstruction and modular prosthetic replacement in proximal femur bone tumors: functional assessment by gait analysis in 20 patients. Acta orthopaedica 2013, 84(2):218-223.
- Stish BJ, Ahmed SK, Rose PS, Arndt CA, Laack NN: Patient-Reported Functional and Quality of Life Outcomes in a Large Cohort of Long-Term Survivors of Ewing Sarcoma. Pediatric blood & cancer 2015, 62(12):2189-2196.
- Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM et al: Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005, 23(9):2004-2011.
- Granowetter L, Womer R, Devidas M, Krailo M, Wang C, Bernstein M, Marina N, Leavey P, Gebhardt M, Healey J et al: Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children’s Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009, 27(15):2536-2541.
- Davis AM, Wright JG, Williams JI, Bombardier C, Grifin A, Bell RS: Development of a measure of physical function for patients with bone and soft tissue sarcoma. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1996, 5(5):508-516.
- Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ: A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clinical orthopaedics and related research 1993(286):241-246.
- Li J, Thompson TD, Miller JW, Pollack LA, Stewart SL: Cancer incidence among children and adolescents in the United States, 2001-2003. Pediatrics 2008, 121(6):e1470-1477.
- Wiangnon S, Veerakul G, Nuchprayoon I, Seksarn P, Hongeng S, Krutvecho T, Sripaiboonkij N: Childhood cancer incidence and survival 2003-2005, Thailand: study from the Thai Pediatric Oncology Group. Asian Pacific journal of cancer prevention : APJCP 2011, 12(9):2215-2220.
- Lietman SA, Joyce MJ: Bone sarcomas: Overview of management, with a focus on surgical treatment considerations. Cleveland Clinic journal of medicine 2010, 77 Suppl 1:S8-12.
- Choi EY, Gardner JM, Lucas DR, McHugh JB, Patel RM: Ewing sarcoma. Seminars in diagnostic pathology 2014, 31(1):39-47.
- Widhe B, Widhe T: Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma. The Journal of bone and joint surgery American volume 2000, 82(5):667-674.
- Nakamura T, Grimer RJ, Gaston CL, Watanuki M, Sudo A, Jeys L: The prognostic value of the serum level of C-reactive protein for the survival of patients with a primary sarcoma of bone. The bone & joint journal 2013, 95-B(3):411-418.
- Arndt CA, Rose PS, Folpe AL, Laack NN: Common musculoskeletal tumors of childhood and adolescence. Mayo Clinic proceedings 2012, 87(5):475-487.
- Moore DD, Haydon RC: Ewing’s sarcoma of bone. Cancer treatment and research 2014, 162:93-115.
- Moore DD, Luu HH: Osteosarcoma. Cancer treatment and research 2014, 162:65-92.
- Tunn PU, Pomraenke D, Goerling U, Hohenberger P: Functional outcome after endoprosthetic limb-salvage therapy of primary bone tumours-a comparative analysis using the MSTS score, the TESS and the RNL index. International orthopaedics 2008, 32(5):619-625.
- Aksnes LH, Bauer HC, Jebsen NL, Folleras G, Allert C, Haugen GS, Hall KS: Limb-sparing surgery preserves more function than amputation: a Scandinavian sarcoma group study of 118 patients. The Journal of bone and joint surgery British volume 2008, 90(6):786-794.
- Womer RB, West DC, Krailo MD, Dickman PS, Pawel BR, Grier HE, Marcus K, Sailer S, Healey JH, Dormans JP et al: Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children’s Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012, 30(33):4148-4154.
- Bielack SS, Kempf-Bielack B, Branscheid D, Carrle D, Friedel G, Helmke K, Kevric M, Jundt G, Kuhne T, Maas R et al: Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009, 27(4):557-565.